Cited by 285Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchBlood Coagulation and Thrombosis Mechanisms

Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.

Open access
Ridker, P M, Manson, J E, Buring, J E, Muller, J E, Hennekens, C H·1990·Circulation

Abstract

Increased platelet aggregation in the morning and upon assuming an upright posture may account at least in part for the observed circadian variation in onset of acute myocardial infarction. The Physicians' Health Study, a randomized, double-blind, placebo-controlled trial of alternate-day aspirin intake (325 mg) among 22,071 US male physicians, afforded the opportunity to assess this circadian pattern and examine whether it is altered by aspirin therapy. During a 5-year period of follow-up, 342 cases of nonfatal myocardial infarction were confirmed, of which the time of onset was available in 211 (62%). The placebo group showed a bimodal circadian variation in onset of myocardial infarction with a primary peak between 4:00 AM and 10:00 AM (p less than 0.001). In the aspirin group, however, this circadian variation was minimal (p = 0.16), due primarily to a marked reduction in the morning peak of infarction. Specifically, aspirin was associated with a 59.3% reduction in the incidence of infarction during the morning waking hours, compared with a 34.1% reduction for the remaining hours of the day. The greater reduction was observed during the 3-hour interval immediately after awakening, a period with a risk of infarction twice that of any other comparable time interval (p less than 0.001). Aspirin intake was associated with a mean reduction in the incidence of infarction of 44.8% over the entire 24-hour cycle. These data support the hypothesis that increased platelet aggregability in the morning and upon arising contributes to the occurrence of myocardial infarction and that aspirin reduces the risk of infarction by inhibiting platelet aggregation during these critical periods.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.82.3.897

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Aspirin reduces the morning peak in myocardial infarction, suggesting that the prothrombotic milieu in the morning is partly responsible for increased cardiovascular risk during that period.

    “Indeed, aspirin reduces the morning peak in myocardial infarction (116), suggesting that the prothrombotic milieu in the morning is partly responsible for increased CV risk during that period.”

    From Role of the circadian system in cardiovascular disease (2018) · cites this paper as [116]

  • Low-dose aspirin can reduce the morning peak in myocardial infarction by approximately 60%.

    “Likewise, low-dose aspirin can reduce the morning peak in myocardial infarction by approximately 60% (116), with evening aspirin theoretically being best to reduce potential for thrombus formation across the morning vulnerable period, although evidence from placebo-controlled trials with long-term follow up of CV outcomes is lacking (177).”

    From Role of the circadian system in cardiovascular disease (2018) · cites this paper as [116]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 9

  1. Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery I, Schroder R, and the ISAM Study Group: Increased morning incidence of myocardial infarction in the ISAM study: Absence with prior /8-adrenergic blockade. Cir- culation 1989;80:853-858
  2. Petralito A, Mangiafico RA, Gibiino S, Cuffari MA, Miano MF, Fiore CE: Daily modifications of plasma fibrinogen, platelet aggregation, Howell's time, PTT, TT, and antithrom- bin III in normal subjects and in patients with vascular disease. Chronobiologia 1982;9:195-201
  3. Brezinski DA, Tofler GH, Muller JE, Pohjola-Sintonen S, Willich SN, Schafer AI, Czeisler CA, Williams GH: Morning increase in platelet aggregability: Association with assumption of the upright posture. Circulation 1988;78:35-40
  4. Muller JE, Tofler GH: Circadian variation in onset of cardio- vascular disease, in Braunwald E (ed): Heart Disease: Clinical Update. Philadelphia, WB Saunders, 1988, pp 13-24
  5. Churina SK, Ganelina IE, Volpert EI: On the distribution of the incidence of acute myocardial infarction within a 24-hour period. Kardiologiia 1975;15:115-118
  6. Gyarfas I, Csukas A, Horvath-Gaudi I: Analysis of the diurnal periodicity of acute myocardial infarction attacks. Sante Pub- lique (Bucur) 1976;19:77-84
  7. Ganelina IE, Borisova IY: Circadian rhythm in working capac- ity, sympathicoadrenal activity, and myocardial infarction. Hum Physiol 1983;9:113-120
  8. Hjalmarson A, Gilpin EA, Nicod P, Dittrich H, Henning H, Engler R, Blacky AR, Smith SC, Ricou F, Ross J Jr: Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction. Circulation 1989;80:267-275
  9. Kleiman NS, Schechtman KB, Young PM, Goodman DA, Boden WE, Pratt CM, Roberts R, and the Diltiazem Rein- farction Study Investigators: Lack of diurnal variation in the onset of non-Q wave infarction. Circulation 1990;81:548-555

Cited by

Sorted by citations

Authors
Ridker, P. M., Manson, J. E., Buring, J. E., Muller, J. E., & Hennekens, C. H.
Affiliations
Brigham and Women's Hospital (US)
Venue
Circulation
Published
1990-09
Volume
82
Issue
3
Pages
897-902
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1986422577
Cited by
285
References
24
Citations by year
2026: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 6 · 2016: 3 · 2015: 5 · 2014: 8 · 2013: 6 · 2012: 9
FWCI
14.32
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (CA 34944, HL-26490)
  • National Heart, Lung, and Blood Institute (HL-34595, HL07575, HL 26490, CA-34944, R01HL034595)
  • National Cancer Institute (CA 34944)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
acute myocardial infarction, circadian variation, low-dose aspirin, platelet aggregation, morning peak, onset time, Physicians' Health Study, aspirin therapy, cardiovascular risk reduction
MeSH terms
Adult, Aged, Aged, 80 and over, Aspirin, Circadian Rhythm, Humans, Male, Middle Aged, Myocardial Infarction, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review